Objective: To document the effects of two doses of dexmedetomidine on the induction characteristics and dose requirements of alfaxalone.
Study Design: Randomized controlled clinical trial.
Animals: Sixty one client owned dogs, status ASA I-II.
Objective: To evaluate the clinical efficacy and cardiorespiratory effects of alfaxalone as an anaesthetic induction agent in dogs with moderate to severe systemic disease.
Study Design: Randomized prospective clinical study.
Animals: Forty dogs of physical status ASA III-V referred for various surgical procedures.
Objective: To compare the recovery after anaesthesia with isoflurane, sevoflurane and desflurane in dogs undergoing magnetic resonance imaging (MRI) of the brain.
Study Design: Prospective, randomized clinical trial.
Animals: Thirty-eight dogs weighing 23.